JonathanBarratt University of Leicester, Leicester, UKUnited Kingdom

JonathanBarratt
My research is focussed on a bench to bedside approach to improving our understanding of the pathogenesis of IgA nephropathy a common global cause of kidney failure. I am the IgA nephropathy Rare Disease Group lead for the UK National Registry of Rare Kidney Diseases (RaDaR) and Convener of the International IgA Nephropathy Network. I work closely with pharmaceutical companies interested in new treatments for IgA nephropathy, and am Chief Investigator for a number of international randomised controlled Phase 2 and 3 clinical trials in IgA nephropathy. I was a member of the FDA and American Society of Nephrology Kidney Health Initiative: Identifying Surrogate Endpoints for Clinical Trials in IgA Nephropathy Work group. I am an Editorial Board member for Kidney International and the American Society of Nephrology journals. I am a co-Chair of the UK Glomerulonephritis Clinical Study Group and am the IgA nephropathy lead for the KDIGO Clinical Practice Guidelines for Glomerular Diseases.
Institution

Day 1 - Sunday April 14, 2024

Time Session
10:30 a.m.
11 a.m.
JonathanBarratt Spotlight Speaker jb81@leicester.ac.ukUniversity of Leicester, Leicester, UKUnited Kingdom
Spotlight Stage 1 (exhibition hall)

Day 2 - Monday April 15, 2024

Time Session
3 p.m.
4 p.m.
AlessiaFornoni Chairperson afornoni@med.miami.eduUnited States
MichelleRheault Chairperson rheau002@umn.eduUniversity of MinnesotaUnited States
  • Predicting the Risks of Kidney Failure and Death in Adults With Moderate-to-severe Chronic Kidney Disease (KDpredict)
    PietroRavani Free Communication pravani@ucalgary.caUniversity of CalgaryCanada
  • Plasma Exchange in ANCA Associated Vasculitis GN: Update After Pexivas – Recommendations and Updates
    Wladimir MietekSzpirt Speaker wladimir.mietek.szpirt.01@regionh.dkRigshospitalet, University of Copenhagen, Dept. of Nephrology, Denmark, Senior Research ConsultantDenmark
  • EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY
    DanaRizk Free Communication drizk@uabmc.eduUniversity of Alabama at BirminghamUnited States
  • SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL
    JonathanBarratt Free Communication jb81@leicester.ac.ukUniversity of Leicester, Leicester, UKUnited Kingdom
  • PREGNANCY AMONG WOMEN ON CHRONIC DIALYSIS : THE FRENCH COHORT
    CécileCouchoud Free Communication cecile.couchoud@biomedecine.frREIN registry, Agence de la biomédecine, FranceFrance
Hall A
4:30 p.m.
5:30 p.m.
DebbieGipson Chairperson debbie.gipson@nih.govNational Institutes of Health/NIDDKUnited States
JonathanBarratt Chairperson jb81@leicester.ac.ukUniversity of Leicester, Leicester, UKUnited Kingdom
  • Patients Subphenotyping: The Example of Diabetic Kidney Disease
    John CijiangHe Speaker cijiang.he@mssm.eduIcahn School of Medicine at Mount SinaiUnited States
  • Power of AI to Develop Data-driven Early Detection, Diagnosis, and Management of Kidney Disease
    LauraMariani Speaker lmariani@umich.eduUniversity of MichiganUnited States
  • Targeted Approaches in Clinical Trial Design
    HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands
  • Q and A
Hall D

Pre-Congress - Saturday April 13, 2024

Time Session
9 a.m.
11 a.m.
AdrianLiew Chairperson draliew2@gmail.comMount Elizabeth Novena Hospital, SingaporeSingapore
HeatherReich Chairperson Heather.Reich@uhn.caUniversity of Toronto, University Health NetworkCanada
HernánTrimarchi Chairperson htrimarchi@hotmail.comHOSPITAL BRITÁNICO DE BUENOS AIRESArgentina
JonathanBarratt Chairperson jb81@leicester.ac.ukUniversity of Leicester, Leicester, UKUnited Kingdom
  • Histophysiology of the Glomerulus
    SoniaChicano Speaker sonialchicano@yahoo.comISNPhilippines
  • Overview of Immunosuppression
    DanaRizk Speaker drizk@uabmc.eduUniversity of Alabama at BirminghamUnited States
  • Genetic Testing in Glomerular Diseases
    KeishaGibson Speaker keisha_gibson@med.unc.eduUniversity of North Carolina at Chapel Hill, USAUnited States
  • Approach to RPGN
    ArennJauhal Speaker Arenn.Jauhal@uhn.caCanada
  • Case Presentation and Discussion 1
    HernánTrimarchi Speaker htrimarchi@hotmail.comHOSPITAL BRITÁNICO DE BUENOS AIRESArgentina
Hall E
11:30 a.m.
1:30 p.m.
AdrianLiew Chairperson draliew2@gmail.comMount Elizabeth Novena Hospital, SingaporeSingapore
HeatherReich Chairperson Heather.Reich@uhn.caUniversity of Toronto, University Health NetworkCanada
HernánTrimarchi Chairperson htrimarchi@hotmail.comHOSPITAL BRITÁNICO DE BUENOS AIRESArgentina
JonathanBarratt Chairperson jb81@leicester.ac.ukUniversity of Leicester, Leicester, UKUnited Kingdom
  • Approach to Nephrotic Syndrome
    Chee KayCheung Speaker ckc15@leicester.ac.ukUniversity of LeicesterUnited Kingdom
  • Case Presentation and Discussion 2
    MarinaVivarelli Speaker marina.vivarelli@opbg.netLaboratory of Nephrology, Bambino Gesù Children's HospitalItaly
  • Case Presentation and Discussion 3
    KeishaGibson Speaker keisha_gibson@med.unc.eduUniversity of North Carolina at Chapel Hill, USAUnited States
  • Case Presentation and Discussion 4
    HeatherReich Speaker Heather.Reich@uhn.caUniversity of Toronto, University Health NetworkCanada
Hall E
2:15 p.m.
4:15 p.m.
AdrianLiew Chairperson draliew2@gmail.comMount Elizabeth Novena Hospital, SingaporeSingapore
HeatherReich Chairperson Heather.Reich@uhn.caUniversity of Toronto, University Health NetworkCanada
HernánTrimarchi Chairperson htrimarchi@hotmail.comHOSPITAL BRITÁNICO DE BUENOS AIRESArgentina
JonathanBarratt Chairperson jb81@leicester.ac.ukUniversity of Leicester, Leicester, UKUnited Kingdom
  • Approach to Nephritic Syndrome
    HernánTrimarchi Speaker htrimarchi@hotmail.comHOSPITAL BRITÁNICO DE BUENOS AIRESArgentina
  • Case Presentation and Discussion 5
    Prof LizLightstone Speaker l.lightstone@imperial.ac.ukImperial College LondonUnited Kingdom
  • Case Presentation and Discussion 6
    JonathanBarratt Speaker jb81@leicester.ac.ukUniversity of Leicester, Leicester, UKUnited Kingdom
  • Case Presentation and Discussion 7
    AdrianLiew Speaker draliew2@gmail.comMount Elizabeth Novena Hospital, SingaporeSingapore
Hall E